ALXN - Alexion Pharmaceuticals Inc. (ALXN) CEO Ludwig Hantson on Q1 2020 Results - Earnings Call Transcript
Alexion Pharmaceuticals, Inc. (ALXN)
Q1 2020 Results Earnings Conference Call
May 06, 2020, 08:00 AM ET
Company Participants
Chris Stevo - Head of Investor Relations
Ludwig Hantson - Chief Executive Officer
Aradhana Sarin - Chief Financial Officer
John Orloff - Global Head of R&D
Brian Goff - Chief Commercial and Global Operations Officer
Conference Call Participants
Cory Kasimov - JPMorgan
Geoffrey Porges - SVB Leerink
Chris Raymond - Piper Sandler
Paul Matteis - Stifel
Geoff Meacham - Bank of America
Mohit Bansal - Citigroup
Phil Nadeau - Cowen & Company
Robyn Karnauskas - SunTrust
Matthew